Dr. Jens Wiehler 

  •                                 
    Extbase Variable Dump
    'distribution:BiomSpeaker.html' (29 chars)
    
                            
  •                                     
    Extbase Variable Dump
    'fileadmin/Webdata/digimed/Symposium_2024/Fotos/Foto_Lars_Maegdefessel_300x30
     0.png    ' (81 chars)
    
                                
  •                                     
    Extbase Variable Dump
    'Prof. Dr. Lars Mägdefessel' (26 chars)
    
                                
  •                                     
    Extbase Variable Dump
    'Director, Institute of Molecular Vascular Medicine, TUM University Hospital' (75 chars)
    
                                
  •                                     
    Extbase Variable Dump
    'Lars Maegdefessel studied medicine at the Johannes Gutenberg University in M
     ainz, Germany. Upon completion of his medical studies and finalizing his doc
     torate, he became a Clinical fellow in Cardiology and Vascular Medicine in M
     ainz, before moving to Stanford University as a Postdoctoral research fellow
     . In 2012 he was recruited as an Assistant Professor in Experimental Vascula
     r Medicine to the Karolinska Institute, Stockholm, Sweden. In 2016 he starte
     d having a dual affiliation between Stockholm and the Technical University i
     n Munich (TUM), Germany, where he has recently been promoted to become the D
     irector of the newly formed Institute of Molecular Vascular Medicine at TUM.
      Research in Dr. Maegdefessel’s laboratories in Munich and Stockholm focuses
      on the therapeutic and biomarker potential of non-coding RNAs in vascular d
     iseases. The two main vascular diseases he is interested in are abdominal ao
     rtic aneurysms as well as carotid artery disease and ischemic forms of strok
     e. The labs have access to various human biobanks and cohorts, in vivo and i
     n vitro models (organs-on-chips) and utilize multiple Omics approaches to un
     ravel novel molecular targets with relevance to vascular disease development
      and progression. Dr. Maegdefessel has been awarded research grants and awar
     ds from the European Research Council (Starting and Consolidator), the Germa
     n Research and Swedish Research Councils (DFG and Vetenkapsradet), the Germa
     n Ministry of Education and Research, the Swedish Heart and Lung Foundation,
      the German Center for Cardiovascular Research (DZHK), the National Institut
     e of Health (NIH), as well as the American Heart Association (Postdoctoral F
     ellowship Award in 2010). He leads one DigiMed Bayern subproject on personal
     ized medicine approaches for patients with carotid artery diseases and strok
     e.     ' (1827 chars)